The successful experience of industrialized nations proves that health systems, when coordinated with technological development, can also generate goods and services that are crucial for economic development. Like many low- and middle-income countries, sub-Saharan African nations also aspire to develop their pharmaceutical industry by promoting access to affordable quality medicine. Many countries are taking restrictive measures during the current Covid-19 pandemic to secure adequate access to medical products. The lockdown in China and India due to the Covid-19 pandemic has resulted in a huge market gap. Against such a backdrop, this paper will discuss the issue of scaling up the local pharmaceutical production in Africa as an opportunity, as well as a necessity, to tackle local epidemics and non-communicable diseases whose control could be undermined by the scale of the Covid-19 outbreak.